Whether you searched orlistat reviews UK, orlistat UK reviews, orlistat review UK, orlistat weight loss reviews or simply orlistat review, you are probably asking one question: will this work for me, and how much weight might I lose?
There is no way to predict your individual result from a review. A better place to start is the clinical evidence, which has followed thousands of people over several years. There is also a useful checkpoint at 12 weeks that helps prescribers decide whether continuing treatment is appropriate. This guide covers both, explains why you will not find before and after images on UK pharmacy sites, and looks at what you might expect during the first few weeks.
Key things to know
- Orlistat reduces the amount of dietary fat your body absorbs. It does not work by reducing appetite, so your eating pattern is an important part of treatment
- In long-term trials, orlistat alongside lifestyle changes produced more weight loss than lifestyle changes alone. The average difference was modest rather than dramatic
- UK advertising rules do not allow prescription-only medicines to be advertised to the public, and before and after photographs can be treated as advertising claims for these medicines. This is one reason you will not find them on a UK pharmacy site
- The important checkpoint is a 12-week review, rather than judging the medicine after just one month
- Reviews can vary a lot because people respond differently, and diet and lifestyle can have a major effect on the results and side effects
Why You Will Not Find Orlistat Before and After Pictures Here
This is worth explaining rather than simply leaving the images out, because it affects what you can and cannot find online.
Orlistat 120mg is a prescription-only medicine in the UK. Prescription-only medicines cannot be advertised directly to the public. The ASA also states that before and after photographs of prescription-only medicines are likely to be treated as advertising and should not be used in marketing communications.
This means a UK pharmacy should not publish an orlistat before and after gallery as a way of promoting the medicine. The same applies to pages built around patient success stories, particularly where they promote a prescription-only medicine or make specific weight-loss claims.
This is why searches for orlistat before and after pictures, orlistat reviews before and after pictures, orlistat weight loss before and after, or simply orlistat before after may bring up websites that are not operating under the same UK advertising rules. If you find a gallery, check who published it and whether it is actually advertising a UK prescription-only medicine.
There is another reason to be careful with before and after photographs. They are not a reliable way to judge how a medicine will work for you. Lighting, posture, clothing, camera angle and other factors can change how someone's body looks in a photograph. Published images may also represent selected experiences rather than typical results.
Clinical studies give you a more useful starting point because they measure weight changes across groups of people rather than showing only selected individual stories.
Orlistat Weight Loss Results: What the Evidence Shows
One of the largest and longest studies of orlistat followed 3,305 adults with obesity for four years. It compared orlistat alongside a lifestyle programme with placebo alongside the same lifestyle programme.
| Outcome over four years | Orlistat plus lifestyle | Placebo plus lifestyle |
|---|---|---|
| Mean weight loss | 5.8kg | 3.0kg |
| New cases of type 2 diabetes | 6.2% | 9.0% |
| Completed the four years | 52% | 34% |
Three things are worth taking from these results.
First, both groups lost weight. The lifestyle programme was part of both treatments. The average weight loss was 5.8kg with orlistat compared with 3.0kg with placebo after four years. That means the difference between the groups was about 2.8kg. It is a real difference, but it was not a dramatic transformation for everyone.
Second, the diabetes finding needs some context. The difference in new cases of type 2 diabetes was mainly seen among people who had impaired glucose tolerance when they entered the study. It should not be taken to mean that orlistat prevents diabetes in everyone.
Third, not everyone completed the four-year study. About half of the orlistat group completed the trial, compared with around one third of the placebo group. This is important when reading long-term trial results because the people who complete a study may differ from those who stop taking part.
Separately, a 52-week trial in people with type 2 diabetes who were taking metformin, either alone or with a sulphonylurea, found an average weight change of 5.0% with orlistat compared with 1.8% with placebo. The orlistat group also had a greater reduction in HbA1c.
These figures are averages from clinical trials. They are useful for understanding what happened across a study group, but they cannot tell you exactly how much weight you will lose.
One Month Orlistat Before and After: What Four Weeks Looks Like
Searches for one month orlistat before and after are common, but four weeks is usually too early to decide how well the treatment is working.
During the first month, you may notice the effect of your meals on your bowel habits before you notice a large change on the scales. Orlistat can cause gastrointestinal side effects, particularly after meals that contain more fat. This can make the connection between food choices and side effects quite noticeable.
On the scales, weight loss during the first month can vary from person to person. Any early change can also include changes in body water, particularly if you have made significant changes to your diet at the same time. It is therefore better to look at your overall progress over several weeks rather than focusing on one weigh-in.
If you want to take photographs to track your own progress, you can take them at regular intervals under similar conditions, such as the same room, lighting and clothing. Just remember that photographs are a personal way of tracking change, not a reliable way to predict how much weight you should lose.
The Real Checkpoint Is 12 Weeks
The 12-week review is more useful than relying on online reviews or trying to judge the medicine after only a few weeks.
UK product information states that orlistat should be discontinued after 12 weeks if you have not lost at least 5% of your starting body weight. Your prescriber can use this review to assess whether the treatment is helping and whether it is appropriate to continue.
For example, if you started at 100kg, 5% would be 5kg. The 5% figure is a treatment checkpoint, not a promise that everyone will lose 5kg.
It is also worth remembering that weight loss is only one part of the review. Your prescriber may consider your overall health, side effects, eating pattern and whether you are finding the treatment manageable.
Why Orlistat Reviews Vary So Much
Read enough orlistat reviews weight loss forums and you will find people who say it worked well for them and others who found it disappointing or difficult to tolerate. Both can be genuine experiences.
Your starting weight, diet, lifestyle, other medicines and how your body responds can all affect your experience. The medicine also works differently from treatments that reduce appetite.
What a Negative Review Usually Means
Two common reasons for poor experiences are expecting appetite suppression and finding the bowel side effects difficult to manage.
Orlistat does not work by reducing hunger. It works in the gut by reducing the absorption of some of the fat you eat. If you start it expecting the appetite effects associated with some injectable weight-management medicines, you may feel that it is not doing what you expected.
Diet also matters. Orlistat-related side effects can include oily or fatty stools, an urgent need to open your bowels, increased bowel movements and flatulence. These effects can be more noticeable after meals containing more fat.
That is why orlistat is used alongside a reduced-calorie, lower-fat diet. The diet is an important part of how the treatment is used, rather than an optional extra.
What a Positive Review Usually Describes
People who have a positive experience may describe feeling that the treatment fits well with their eating habits and weight-management plan.
Some people find the link between eating higher-fat meals and bowel side effects useful because it makes them more aware of their food choices. Others may find those effects difficult or unpleasant. There is no single experience that applies to everyone.
If you are having persistent or troublesome side effects, speak to your pharmacist or prescriber rather than relying on other people's reviews.
What Actually Determines Your Result
- The fat content of your meals, which can affect both the treatment and the likelihood of gastrointestinal side effects
- Whether you take orlistat as directed with meals that contain fat. If a meal contains no fat, the dose should be omitted according to the product information
- Whether you are also making the recommended dietary and lifestyle changes. Orlistat is intended to be used as part of a wider weight-management plan
- Your starting point and overall health, as people can respond differently to treatment
- Whether you take a multivitamin containing vitamins A, D, E and K at a different time from your orlistat doses, because orlistat can reduce the absorption of fat-soluble vitamins
- Whether you reach the 12-week review and meet the treatment response used to decide whether continuing is appropriate
Orlistat Reviews and the NHS: What Is Actually Published
The NHS does not publish patient reviews or star ratings for medicines, so searches for orlistat reviews NHS will not give you a collection of patient ratings. NHS and NICE information is more useful for understanding who may be offered treatment and how it should be used.
For prescription orlistat, the UK product information states that it is used alongside a mildly hypocaloric diet for adults with a BMI of 30 kg/m² or above, or a BMI of 28 kg/m² or above with associated risk factors.
NICE also recommends using lower BMI thresholds when assessing overweight and obesity in people from South Asian, Chinese, other Asian, Middle Eastern, Black African and African-Caribbean backgrounds because cardiometabolic risk can occur at a lower BMI in these groups.
The lower-strength 60mg version, Alli, is available from pharmacies without a prescription for adults with a BMI of 28 or above. It contains the same active ingredient, orlistat, but at a lower dose. The same general link between dietary fat and gastrointestinal side effects applies.
Orlistat is not suitable for everyone. For example, the prescription product should not be used during pregnancy and is contraindicated in chronic malabsorption syndrome and cholestasis. It can also interact with several medicines, so your medicines and medical history should be checked before treatment is started.
Getting Orlistat in the UK, Wherever You Are
Searches that attach a place name, such as orlistat weight loss treatment Coventry, usually come from people looking for a legitimate local route. The important thing is not simply where the service is based, but whether the medicine is being supplied through an appropriate UK pharmacy and prescribing service.
Registered UK online pharmacies may be able to provide services across the UK, subject to clinical suitability and their service arrangements. Before ordering, check that the pharmacy is registered with the General Pharmaceutical Council and that a suitable clinical assessment is carried out.
A proper assessment should look at your medical history, current medicines, weight and any reasons why orlistat may not be suitable. A legitimate service should be able to decline treatment when it is not clinically appropriate.
If you would rather use the NHS, your GP can assess your circumstances and discuss whether orlistat or another weight-management option is appropriate. Depending on where you live and your circumstances, you may also be referred to a local weight-management service.
Medical Disclaimer
This page provides general information about orlistat and what published evidence shows. It is not personal medical advice, does not recommend a dose, and cannot predict what you will experience.
Weight-loss figures quoted here are averages from clinical trials in defined groups of people, alongside dietary and lifestyle support. Individual results can vary. Orlistat is not suitable for everyone and can interact with other medicines. Speak to a GP, pharmacist or UK-registered prescriber about your circumstances before starting, stopping or changing treatment.
If you experience a suspected side effect from a medicine, you can report it through the MHRA Yellow Card scheme. The Yellow Card scheme helps the MHRA monitor suspected side effects and other safety concerns involving medicines.
